Diet plays a very important role when it comes to your health. There are many people who have to adhere to strict diets because of certain conditions they have. While the basic understanding that we need all kinds of foods to fulfill our body’s needs, sometimes these foods can also cause harm to your body. For example, lactose intolerant people cannot eat or consume any kind of dairy product as their bodies do not have the necessary compounds, known as lactose, to break down dairy foods. Similarly, there are many foods that may be ok for others to consume, but not for people who have digestive issues like IBS. But this new clinical trial may be able to help us know what food we can eat based on our blood test! The blood test, called inFoods IBS, looks for a special type of antibody in the blood. Antibodies are like tiny soldiers that our bodies make to fight off things that could make us sick.

IBS is a very common problem, affecting a large number of people. Many people know that what they eat can make their IBS symptoms worse, but it's often hard to figure out exactly which foods are the culprits. This is because everyone is different, and what triggers one person might not trigger another. Doctors hear from patients all the time, asking for help in determining which foods are causing their problems. So, finding a reliable way to pinpoint those foods is important. This test is attempting to provide that reliability.

How Does This Blood Test Work?

Basically, the test is looking for an antibody called IgG. When the gut reacts badly to a food, it makes more of this IgG antibody. The test checks for reactions to 18 common foods, like wheat, milk, and certain fruits. If the test finds high levels of the IgG antibody for a certain food, it means that food is likely causing problems. Therefore, the patient should try to remove that food from their diet.

Many people with IBS struggle to find relief from their stomach pain and discomfort. This new study looked at whether a special blood test could help. The idea was to see if the test could tell people which foods were making their IBS worse. The results were encouraging. When people changed their diets based on what the blood test showed, about 60% of them felt less stomach pain. This is better than the 42% who felt better when they just tried a general diet change. This shows that the blood test might be a useful tool for people with IBS to get real relief.

How Does This Personalized Nutrition Approach Work?

Many doctors suggest that people with IBS try elimination diets, where they cut out certain foods to see if their symptoms improve. However, these diets can be very hard to follow, because they often require people to cut out a lot of different foods. Doctors are always looking for ways to give patients care that's tailored to their specific needs. In the case of IBS, that means figuring out exactly which foods each person should avoid.

This blood test is a step in that direction. Experts are calling it a move towards "precision nutrition." This means that instead of giving everyone the same diet advice, doctors could use the blood test to create a personalized plan for each patient. While more research is needed, this test brings hope that doctors will soon be able to give much more precise dietary recommendations to those people that suffer from IBS. While this test is yet to be approved by FDA, it could be a world of comfort and ease for people who suffer with IBS.

Actress Lisa Ray was diagnosed with Multiple Myeloma, an incurable but treatable blood cancer, in 2009. She successfully went into remission but experienced a cancer relapse shortly after her wedding in 2012.

During her journey to recovery, she became a prominent advocate for cancer awareness and research. However, it was during this period, at the age of 37, that she also suffered chemo-induced menopause — a topic she brushed aside, not wanting to bring it up out of shame and fear, reflecting the taboo society still associates with the natural end of a woman’s reproductive phase.

In an interaction with HealthandMe, the Oscar-nominated film Water (2005) actress opened up about her experience with chemo-induced menopause.

“I went into chemo-induced menopause at 37. I was given no support. I was completely lost. And even for a subsequent decade after that, I couldn’t find any answers. I didn’t know how to take care of myself. I didn’t know I had options,” she said.

‘I Carried This Burning Secret Inside Me’

The actress shared that she normalized many of her symptoms and avoided speaking openly about menopause despite being candid about cancer.

“I was so vocal about cancer. I’m actually somebody who prefers to be quite truthful about what I’m going through. I don’t really like to hide things. I’m not secretive by nature. And yet, I carried this burning secret inside me for so many years,” she said.

“When I was being lauded as someone who was breaking through the silence of cancer, I was carrying the silent secret inside me. I couldn’t understand why for many years. And I realized today, I was carrying shame.”

She noted that menopause continues to remain a deeply misunderstood and under-discussed subject, despite affecting all women.

‘Menopause Was Like A Black Box’

Lisa said conversations around menopause were absent even within families.

“My mother never talked to me about menopause. Of course, we discussed my period when I got it, but menopause was simply like a black box,” she said.

The actress recalled that discussions around perimenopause and menopause only began when many of her close friends started experiencing symptoms themselves.

Calling the silence around menopause “astonishing” and “extremely unjust,” Lisa said women’s hormonal health continues to be severely underfunded and misunderstood globally.

“Menopause impacts all women. Yet it’s treated like a dark secret,” she told HealthandMe.

Lisa added that once she began researching the issue, she became increasingly frustrated by the lack of awareness and medical attention surrounding menopause and hormonal health.

Menopause Not Getting Enough Attention

The actress said that after moving to Dubai, she began openly discussing menopause on social media, despite initially worrying about public reaction.

“Sometimes in social settings, women would almost shut down or turn away and say, ‘Don’t talk about that.’ But when I put it on social media, maybe it permitted a lot of other women to also find a place to have a conversation or a community,” she said.

To bring about change where women can speak freely about the topic and seek treatment early, Lisa has co-founded NuHer, a science-backed health clinic and platform dedicated to midlife care for women. It is designed to support perimenopause and menopause through personalized medical treatments, clinical psychology, and nutritional guidance.

When asked why she chose to focus on menopause and women’s hormonal health, the Four More Shots Please! actress stated, “Menopause is simply not getting the attention that it needs. Women are struggling to get the care that they need and understand their options.”

Lisa explained that while awareness around cancer has steadily improved in India since her multiple myeloma diagnosis in 2009, menopause remains “the next taboo or frontier.”

According to Lisa, NuHer aims to create a safe, science-backed space where women can access support without judgment or dismissal.

“We need a place where women can be heard, where they’re not dismissed, where they’re not gaslit, where they receive all the right science and the options they can choose for this journey,” she told HealthandMe.

She also criticized the tendency to dismiss menopausal symptoms as a “normal” part of aging without offering support or treatment options.

“Women are not broken. Menopause is not a disease like cancer that has to be cured. But women need support. We don’t need to normalize suffering,” Lisa said.

Menopause Is 'Stepping Into Our Power Age’

Speaking about aging and post-menopause life, Lisa argued that society often dismisses older women despite what she described as a biologically important phase of life.

“We’ve had terrible PR as aging women. We are dismissed and considered irrelevant when actually we’re stepping into our power age if we know how to take care of ourselves,” the acclaimed actress told HealthandMe.

However, the problem arises when menopause is left unaddressed, and the hormonal changes cause long-term health impacts, including bone health, heart disease risk, and possibly dementia.

“The problem is with the drop in hormones. If you don’t have strategies and lifestyle changes to support yourself post-menopause, you become a frail woman. Your bones suffer. You’re more prone to heart disease and possibly even dementia,” she said, urging more women to seek medical help during menopause and not suffer in silence.

GLP-1 agonist drugs like Ozempic, Mounjaro, and Wegovy, may not only help treat obesity and diabetes but also improve survival among breast cancer patients, according to a new study.

The research published in JAMA Network Open suggests that the GLP-1 agonist drugs can lower deaths in breast cancer patients as well as cut down the risk of recurrence of the deadly cancer.

Breast cancer patients who used GLP-1 RA had an overall lower risk of death from any cause over a 10-year follow-up period.

Similarly, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment.

"This study suggests that GLP-1 drugs may offer protective benefits, potentially improving survival and recurrence risk in some female patients with breast cancer—whether this is related to weight control, improved cardiovascular health, or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Chair in Cancer Research at Virginia Commonwealth University’s Massey Comprehensive Cancer Center.

The findings were based on a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023 and also were obese or had type 2 diabetes.

GLP-1 Drugs And Breast Cancer

Also read: World Hypertension Day 2026: Why Switching Salt May Be India’s Simplest Weapon Against High Blood Pressure

Widely hailed as a medical breakthrough, the GLP-1s (glucagon-like peptide-1 receptor agonists) act like the gut hormones that regulate appetite and blood sugar.

It acts specifically on obesity and diabetes — well-established risk factors that significantly elevate the risk of breast cancer progression and recurrence.

GLP-1 medications help lower the risk of breast cancer by promoting weight loss and decreasing circulating tumor activity. It also lowers blood sugar.

Studies have showed that people taking GLP-1s also experience fewer chemo side effects. They were less likely to have anemia, blood clots in veins, low levels of white blood cells called neutrophils, low blood platelet count, sepsis, nausea and vomiting, fatigue, cardiomyopathy, and neuropathy after chemotherapy.

However, the Virginia Commonwealth University study researchers noted that further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes.

Global Burden of Breast Cancer

Read: High Blood Pressure? Daily Soy And Legume Intake May Help Lower The Risk: Study

Breast cancer is the most diagnosed cancer worldwide, accounting for over 2.3 million new cases annually.

According to the WHO's International Agency for Research on Cancer (IARC), it is the leading cause of cancer-related deaths among women, resulting in roughly 670,000 deaths globally each year.

It is also one of the most common cancers among women in the US, and accounts for nearly one-third of all female cancer cases.

The average risk of a woman in the US developing breast cancer sometime in her life is about 13 per cent.

Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival.

-Walk into any salon, and you'll be offered a facial for almost every skin concern under the sun. But somewhere along the way, targeted treatments like de-tanning started giving traditional facials a real run for their money. If your main concern is sun damage, uneven tone, or that stubborn dullness that builds up over weeks of stepping out, the de tan vs facial debate is worth having properly.

The perfect de-tan face mask used consistently at home can deliver results that genuinely rival a salon treatment. It helps you in targeting pigmentation and sun damage right at the source without the appointment, the wait, or the cost. What keeps those results going between sessions is just as important. A daily de-tan face wash helps prevent surface tan from quietly rebuilding.

So eventually your skin holds onto its progress rather than starting from scratch every week. Here's a proper breakdown of the difference between de-tan and facial so you can make the right call for your skin.

De Tan Vs Facial for Oily Skin

The core difference comes down to what each treatment is actually designed to do.

De Tan is a targeted treatment built around one primary goal. It aims to dissolve surface-level pigmentation and sun damage. It is made up of chemical exfoliants like AHAs, brightening ingredients like vitamin C or kojic acid, and clay formulas that peel away tanned, dead skin cells to expose younger skin underneath.

A facial is a multi-step ritual that addresses overall skin health, not just one specific condition. It usually comprises cleansing, exfoliating, steaming, extraction, massage, and masks. Each phase has a particular objective. A facial is a great way to boost circulation, tackle a range of skin issues all at once, and give your skin a really good refresh.

Maintaining De-Tan Results at Home: A Wiser Approach

Including a targeted de-tan mask in the weekly regimen can help those who want to keep their skin more even-toned and brighter in between salon visits. Exfoliating acids, oil-balancing clays, and barrier-supporting elements fuel a product that targets dullness, uneven texture, and stubborn tan without stripping the skin.

Products like the Foxtale Skin Radiance De-Tan Mask are particularly helpful for oily, mixed, and sun-exposed skin types since they combine light exfoliation with skin-brightening treatment. Over time, a de-tan treatment at home may make skin seem brighter, fresher, and more radiant when used regularly in conjunction with daily sunscreen.

Which One Suits Your Skin Type?

Oily & Acne-Prone Skin

For oily and acne-prone skin, a targeted de-tan treatment is almost always the safer choice over a traditional facial. Most salon facials designed for brightening use heavy cream-based products, facial massages with oils, and steam, all of which can aggravate acne, clog pores, and trigger fresh breakouts on skin that's already overproducing sebum.

When you use a detan mask with Kaolin Clay and AHAs, it controls excess oil and pigmentation. It does all this without introducing anything that worsens breakouts for you. If you have oily skin, at-home detan treatments done consistently outperform most salon facials in both safety and visible results.

Dry & Dehydrated Skin

A traditional facial that includes a hydrating massage and a nourishing mask can work well here because it addresses moisture levels alongside surface concerns.

That said, a detan treatment isn't off the table for dry skin. The key is picking the right formula, one that uses gentler AHAs like Lactic Acid rather than stronger Glycolic Acid, and that includes hydrating ingredients like Ceramides or Hyaluronic Acid to counterbalance the exfoliation.

Dull & Sun-Damaged Skin

When the skin is suffering from a noticeable tan, uneven tone, and stubborn dullness from sun exposure, a detan treatment is the gold standard of 2026. A facial can provide a glow to your overall tone, but it doesn’t target the melanin deposit that produces your tan and pigmentation. A detan mask with Glycolic Acid, Niacinamide, and brightening clays works on the actual source of the problem, and with consistent use, the results compound over time in a way that a monthly salon facial simply can't replicate.

Which Works Better for Pigmentation and Sun Damage?

Here's a simple way in which you can decide:

Choose a De-Tan when:

• Your main concern is tan, uneven skin tone, or post-sun pigmentation
• You prefer to have targeted, efficient results at home without salon visits
• Your skin is oily or acne-prone and reacts badly to heavy facial products
• You need something you can do consistently every week as part of your routine
• You've just come back from a trip, a wedding season, or an extended time outdoors, and need to reset your skin quickly.

Choose a Facial when:

• Your skin needs an overall reset, not just brightening, but deep cleansing, circulation boost, and hydration together
• You're dealing with multiple concerns at once and want a professional to assess and treat your skin
• Your skin is dry or mature, and benefits from the massage and nourishment steps a facial includes
• You want a one-time intensive treatment before a special occasion rather than an ongoing routine fix.

For most people, the best approach isn't choosing one over the other permanently. In fact, you should understand when each serves your skin best and use them accordingly. A weekly de-tan treatment at home, with an occasional facial when your skin needs a deeper reset, covers most bases without overcomplicating your routine.

Can You Use a De-Tan Mask Instead of a Facial?

The facial vs de-tan debate doesn't have a single winner. It actually depends entirely on what your skin is dealing with and what goal you are trying to achieve. If you have issues with tan, pigmentation, and sun damage, a dedicated detan treatment is a better option for you.

Overall skin health, hydration, and multi-concern maintenance are where a facial earns its place. Know what your skin needs, pick the right tool for the job, and stay consistent; that's where the real results come from.